{"bill":{"bill_id":1372919,"change_hash":"9d21147181184557c007d8089ca698ae","session_id":1658,"session":{"session_id":1658,"state_id":52,"year_start":2019,"year_end":2020,"prefile":0,"sine_die":1,"prior":1,"special":0,"session_tag":"Regular Session","session_title":"2019-2020 Regular Session","session_name":"116th Congress"},"url":"https:\/\/legiscan.com\/US\/bill\/HB7537\/2019","state_link":"https:\/\/www.congress.gov\/bill\/116th-congress\/house-bill\/7537\/all-info","completed":0,"status":1,"status_date":"2020-07-09","progress":[{"date":"2020-07-09","event":1},{"date":"2020-07-09","event":9},{"date":"2020-07-09","event":9}],"state":"US","state_id":52,"bill_number":"HB7537","bill_type":"B","bill_type_id":"1","body":"H","body_id":114,"current_body":"H","current_body_id":114,"title":"Infectious Disease Therapies Research and Innovation Act of 2020","description":"To amend the Internal Revenue Code of 1986 to provide an exception from the passive loss rules for investments in specified medical research small business pass-thru entities.","pending_committee_id":2317,"committee":{"committee_id":2317,"chamber":"H","chamber_id":114,"name":"Ways And Means"},"referrals":[{"date":"2020-07-09","committee_id":2355,"chamber":"H","chamber_id":114,"name":"Subcommittee on Health"}],"history":[{"date":"2020-07-09","action":"Introduced in House","chamber":"H","chamber_id":114,"importance":0},{"date":"2020-07-09","action":"Referred to the Subcommittee on Health.","chamber":"H","chamber_id":114,"importance":1},{"date":"2020-07-09","action":"Referred to the House Committee on Ways and Means.","chamber":"H","chamber_id":114,"importance":1}],"sponsors":[{"people_id":11137,"person_hash":"3ixm419p","party_id":"2","state_id":52,"party":"R","role_id":1,"role":"Rep","name":"Mike Kelly","first_name":"Mike","middle_name":"","last_name":"Kelly","suffix":"","nickname":"","district":"HD-PA-3","ftm_eid":5007914,"votesmart_id":119463,"opensecrets_id":"N00031647","knowwho_pid":286955,"ballotpedia":"Mike_Kelly_(Pennsylvania)","sponsor_type_id":1,"sponsor_order":1,"committee_sponsor":0,"committee_id":0,"state_federal":0}],"sasts":[{"type_id":8,"type":"Related","sast_bill_number":"HB14","sast_bill_id":1381253}],"subjects":[{"subject_id":13338,"subject_name":"Taxation"},{"subject_id":13510,"subject_name":"Accounting and auditing"},{"subject_id":13400,"subject_name":"Advanced technology and technological innovations"},{"subject_id":13139,"subject_name":"Business investment and capital"},{"subject_id":13224,"subject_name":"Income tax credits"},{"subject_id":13276,"subject_name":"Small business"},{"subject_id":13319,"subject_name":"Tax administration and collection, taxpayers"},{"subject_id":13706,"subject_name":"Infectious and parasitic diseases"},{"subject_id":13241,"subject_name":"Medical research"}],"texts":[{"doc_id":2203292,"date":"2020-08-01","type":"Introduced","type_id":1,"mime":"application\/pdf","mime_id":2,"url":"https:\/\/legiscan.com\/US\/text\/HB7537\/id\/2203292","state_link":"https:\/\/www.congress.gov\/116\/bills\/hr7537\/BILLS-116hr7537ih.pdf","text_size":310208,"text_hash":"22d0f493beee4f67f7dc8b6400421bb7"}],"votes":[],"amendments":[],"supplements":[],"calendar":[]}}